ReviewDiabetologia2025

Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.

Melanie R Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.